CORPAY INC (CPAY)

US2199481068 - Common Stock

342.51  -1.32 (-0.38%)

Fundamental Rating

5

Taking everything into account, CPAY scores 5 out of 10 in our fundamental rating. CPAY was compared to 99 industry peers in the Financial Services industry. CPAY has an excellent profitability rating, but there are some minor concerns on its financial health. CPAY has a decent growth rate and is not valued too expensively.



7

1. Profitability

1.1 Basic Checks

In the past year CPAY was profitable.
In the past year CPAY had a positive cash flow from operations.
Each year in the past 5 years CPAY has been profitable.
In the past 5 years CPAY always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 5.75%, CPAY belongs to the top of the industry, outperforming 80.81% of the companies in the same industry.
With an excellent Return On Equity value of 32.83%, CPAY belongs to the best of the industry, outperforming 92.93% of the companies in the same industry.
CPAY has a better Return On Invested Capital (12.10%) than 87.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPAY is above the industry average of 7.84%.
Industry RankSector Rank
ROA 5.75%
ROE 32.83%
ROIC 12.1%
ROA(3y)6.46%
ROA(5y)6.6%
ROE(3y)32.25%
ROE(5y)28.37%
ROIC(3y)12.39%
ROIC(5y)11.79%

1.3 Margins

CPAY has a better Profit Margin (26.14%) than 79.80% of its industry peers.
CPAY's Profit Margin has declined in the last couple of years.
CPAY's Operating Margin of 44.43% is amongst the best of the industry. CPAY outperforms 86.87% of its industry peers.
In the last couple of years the Operating Margin of CPAY has remained more or less at the same level.
Looking at the Gross Margin, with a value of 78.29%, CPAY belongs to the top of the industry, outperforming 85.86% of the companies in the same industry.
In the last couple of years the Gross Margin of CPAY has declined.
Industry RankSector Rank
OM 44.43%
PM (TTM) 26.14%
GM 78.29%
OM growth 3Y2.7%
OM growth 5Y-0.33%
PM growth 3Y-3.94%
PM growth 5Y-4.76%
GM growth 3YN/A
GM growth 5Y-4.8%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPAY is creating some value.
CPAY has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CPAY has less shares outstanding
Compared to 1 year ago, CPAY has an improved debt to assets ratio.

2.2 Solvency

CPAY has an Altman-Z score of 2.27. This is not the best score and indicates that CPAY is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.27, CPAY is doing good in the industry, outperforming 77.78% of the companies in the same industry.
The Debt to FCF ratio of CPAY is 3.34, which is a good value as it means it would take CPAY, 3.34 years of fcf income to pay off all of its debts.
CPAY has a Debt to FCF ratio of 3.34. This is in the better half of the industry: CPAY outperforms 68.69% of its industry peers.
A Debt/Equity ratio of 2.13 is on the high side and indicates that CPAY has dependencies on debt financing.
With a Debt to Equity ratio value of 2.13, CPAY is not doing good in the industry: 65.66% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 3.34
Altman-Z 2.27
ROIC/WACC1.48
WACC8.2%

2.3 Liquidity

A Current Ratio of 1.05 indicates that CPAY should not have too much problems paying its short term obligations.
CPAY has a Current ratio of 1.05. This is comparable to the rest of the industry: CPAY outperforms 47.47% of its industry peers.
A Quick Ratio of 1.05 indicates that CPAY should not have too much problems paying its short term obligations.
CPAY has a Quick ratio (1.05) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05

6

3. Growth

3.1 Past

CPAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.50%, which is quite good.
CPAY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.95% yearly.
The Revenue has been growing slightly by 4.68% in the past year.
The Revenue has been growing by 9.08% on average over the past years. This is quite good.
EPS 1Y (TTM)9.5%
EPS 3Y15.12%
EPS 5Y9.95%
EPS Q2Q%11.36%
Revenue 1Y (TTM)4.68%
Revenue growth 3Y16.3%
Revenue growth 5Y9.08%
Sales Q2Q%6.01%

3.2 Future

CPAY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.72% yearly.
Based on estimates for the next years, CPAY will show a quite strong growth in Revenue. The Revenue will grow by 8.36% on average per year.
EPS Next Y14.56%
EPS Next 2Y15.53%
EPS Next 3Y16.16%
EPS Next 5Y15.72%
Revenue Next Year5.41%
Revenue Next 2Y8.57%
Revenue Next 3Y9.05%
Revenue Next 5Y8.36%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.93, CPAY is valued on the expensive side.
CPAY's Price/Earnings ratio is in line with the industry average.
CPAY's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.17.
The Price/Forward Earnings ratio is 15.17, which indicates a correct valuation of CPAY.
The rest of the industry has a similar Price/Forward Earnings ratio as CPAY.
CPAY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.68.
Industry RankSector Rank
PE 18.93
Fwd PE 15.17

4.2 Price Multiples

61.62% of the companies in the same industry are more expensive than CPAY, based on the Enterprise Value to EBITDA ratio.
CPAY's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CPAY is cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.29
EV/EBITDA 14.1

4.3 Compensation for Growth

CPAY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CPAY may justify a higher PE ratio.
CPAY's earnings are expected to grow with 16.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.3
PEG (5Y)1.9
EPS Next 2Y15.53%
EPS Next 3Y16.16%

0

5. Dividend

5.1 Amount

No dividends for CPAY!.
Industry RankSector Rank
Dividend Yield N/A

CORPAY INC

NYSE:CPAY (12/23/2024, 1:18:05 PM)

342.51

-1.32 (-0.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners96.96%
Inst Owner Change-0.65%
Ins Owners3.09%
Ins Owner Change5.56%
Market Cap23.88B
Analysts80
Price Target403.48 (17.8%)
Short Float %2.09%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.25%
Min EPS beat(2)-1.45%
Max EPS beat(2)-1.06%
EPS beat(4)0
Avg EPS beat(4)-1.77%
Min EPS beat(4)-2.8%
Max EPS beat(4)-1.06%
EPS beat(8)2
Avg EPS beat(8)-1.13%
EPS beat(12)5
Avg EPS beat(12)0%
EPS beat(16)8
Avg EPS beat(16)0.65%
Revenue beat(2)0
Avg Revenue beat(2)-1.76%
Min Revenue beat(2)-1.82%
Max Revenue beat(2)-1.7%
Revenue beat(4)0
Avg Revenue beat(4)-2.76%
Min Revenue beat(4)-5.28%
Max Revenue beat(4)-1.7%
Revenue beat(8)1
Avg Revenue beat(8)-2.01%
Revenue beat(12)4
Avg Revenue beat(12)-0.74%
Revenue beat(16)7
Avg Revenue beat(16)-0.49%
PT rev (1m)13.27%
PT rev (3m)23.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.25%
EPS NY rev (1m)0.19%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.75%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 18.93
Fwd PE 15.17
P/S 6.16
P/FCF 10.29
P/OCF 9.59
P/B 7.73
P/tB N/A
EV/EBITDA 14.1
EPS(TTM)18.09
EY5.28%
EPS(NY)22.58
Fwd EY6.59%
FCF(TTM)33.3
FCFY9.72%
OCF(TTM)35.71
OCFY10.43%
SpS55.62
BVpS44.29
TBVpS-71.63
PEG (NY)1.3
PEG (5Y)1.9
Profitability
Industry RankSector Rank
ROA 5.75%
ROE 32.83%
ROCE 18.55%
ROIC 12.1%
ROICexc 13.79%
ROICexgc 105.25%
OM 44.43%
PM (TTM) 26.14%
GM 78.29%
FCFM 59.87%
ROA(3y)6.46%
ROA(5y)6.6%
ROE(3y)32.25%
ROE(5y)28.37%
ROIC(3y)12.39%
ROIC(5y)11.79%
ROICexc(3y)14.91%
ROICexc(5y)14.06%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.48%
ROCE(5y)16.34%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y7.76%
ROICexc growth 5Y0.13%
OM growth 3Y2.7%
OM growth 5Y-0.33%
PM growth 3Y-3.94%
PM growth 5Y-4.76%
GM growth 3YN/A
GM growth 5Y-4.8%
F-Score7
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 3.34
Debt/EBITDA 3.19
Cap/Depr 48.94%
Cap/Sales 4.32%
Interest Coverage 3.51
Cash Conversion 120.51%
Profit Quality 229.02%
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 2.27
F-Score7
WACC8.2%
ROIC/WACC1.48
Cap/Depr(3y)43.97%
Cap/Depr(5y)38.02%
Cap/Sales(3y)4.15%
Cap/Sales(5y)3.71%
Profit Quality(3y)130.29%
Profit Quality(5y)142.06%
High Growth Momentum
Growth
EPS 1Y (TTM)9.5%
EPS 3Y15.12%
EPS 5Y9.95%
EPS Q2Q%11.36%
EPS Next Y14.56%
EPS Next 2Y15.53%
EPS Next 3Y16.16%
EPS Next 5Y15.72%
Revenue 1Y (TTM)4.68%
Revenue growth 3Y16.3%
Revenue growth 5Y9.08%
Sales Q2Q%6.01%
Revenue Next Year5.41%
Revenue Next 2Y8.57%
Revenue Next 3Y9.05%
Revenue Next 5Y8.36%
EBIT growth 1Y7.53%
EBIT growth 3Y19.44%
EBIT growth 5Y8.72%
EBIT Next Year28.85%
EBIT Next 3Y17.32%
EBIT Next 5Y16.19%
FCF growth 1Y160.37%
FCF growth 3Y11.78%
FCF growth 5Y18.83%
OCF growth 1Y140.22%
OCF growth 3Y12.58%
OCF growth 5Y18.39%